Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Apr;48(4):387–389. doi: 10.1136/jcp.48.4.387

Acquired protein S deficiency in a patient with systemic lupus erythematosus causing central retinal vein thrombosis.

H M Prince 1, P J Thurlow 1, R C Buchanan 1, K M Ibrahim 1, P J Neeson 1
PMCID: PMC502564  PMID: 7615865

Abstract

A 16 year old girl with systemic lupus erythematosus (SLE) developed the rare complication of central retinal vein occlusion. Although classically a disease of older patients, it has been recognised in association with SLE but only in the presence of the lupus anticoagulant or antiphospholipid antibodies. The thrombosis occurred when free protein S concentrations were transiently reduced and there was no family history or other known causes of reduced protein S concentrations. No other prothrombotic risk factors were present.

Full text

PDF
387

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnum S. R., Dahlbäck B. C4b-binding protein, a regulatory component of the classical pathway of complement, is an acute-phase protein and is elevated in systemic lupus erythematosus. Complement Inflamm. 1990;7(2):71–77. doi: 10.1159/000463131. [DOI] [PubMed] [Google Scholar]
  2. D'Angelo A., Della Valle P., Crippa L., Pattarini E., Grimaldi L. M., Viganò D'Angelo S. Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med. 1993 Jun 17;328(24):1753–1757. doi: 10.1056/NEJM199306173282405. [DOI] [PubMed] [Google Scholar]
  3. Dahlbäck B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost. 1991 Jul 12;66(1):49–61. [PubMed] [Google Scholar]
  4. Griffin J. H., Gruber A., Fernández J. A. Reevaluation of total, free, and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood. 1992 Jun 15;79(12):3203–3211. [PubMed] [Google Scholar]
  5. Keeling D. M., Campbell S. J., Mackie I. J., Machin S. J., Isenberg D. A. Total and free protein S in systemic lupus erythematosus. Thromb Res. 1990 Nov 1;60(3):237–240. doi: 10.1016/0049-3848(90)90185-f. [DOI] [PubMed] [Google Scholar]
  6. Kohner E. M., Cappin J. M. Do medical conditions have an influence on central retinal vein occlusions? Proc R Soc Med. 1974 Oct;67(10):1052–1054. doi: 10.1177/003591577406701037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Snyers B., Lambert M., Hardy J. P. Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies. Retina. 1990;10(4):255–260. doi: 10.1097/00006982-199010000-00005. [DOI] [PubMed] [Google Scholar]
  8. Thorisdottir H., Evans J. A., Schwartz H. J., Comp P., Haluschak J., Ratnoff O. D. Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. J Lab Clin Med. 1992 Jun;119(6):698–701. [PubMed] [Google Scholar]
  9. Vine A. K., Samama M. M. The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions. Surv Ophthalmol. 1993 Jan-Feb;37(4):283–292. doi: 10.1016/0039-6257(93)90011-u. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES